Somatic Hypermutation at A/T-Rich Oligonucleotide Substrates Shows Different Strand Polarities in Ung-Deficient or -Proficient Backgrounds

REFERENCES

• Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553–563. http://dx.doi.org/10.1016/S0092-8674(00)00078-7.
   PubMed Web of Science ®Google Scholar
• Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102:565–575. http://dx.doi.org/10.1016/S0092-8674(00)00079-9.
   PubMed Web of Science ®Google Scholar
• Rada C, Di Noia JM, Neuberger MS. 2004. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16:163–171. http://dx.doi.org/10.1016/j.molcel.2004.10.011.
   PubMed Web of Science ®Google Scholar
• Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T, Neuberger MS. 2002. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12:1748–1755. http://dx.doi.org/10.1016/S0960-9822(02)01215-0.
   PubMed Web of Science ®Google Scholar
• Jansen JG, Langerak P, Tsaalbi-Shtylik A, van den Berk P, Jacobs H, de Wind N. 2006. Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice. J. Exp. Med. 203:319–323. http://dx.doi.org/10.1084/jem.20052227.
   PubMed Web of Science ®Google Scholar
• Delbos F, Aoufouchi S, Faili A, Weill JC, Reynaud CA. 2007. DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 204:17–23. http://dx.doi.org/10.1084/jem.20062131.
   PubMedGoogle Scholar
• Langerak P, Nygren AO, Krijger PH, van den Berk PC, Jacobs H. 2007. A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification. J. Exp. Med. 204:1989–1998. http://dx.doi.org/10.1084/jem.20070902.
   PubMed Web of Science ®Google Scholar
• Weill JC, Reynaud CA. 2008. DNA polymerases in adaptive immunity. Nat. Rev. Immunol. 8:302–312. http://dx.doi.org/10.1038/nri2281.
   PubMed Web of Science ®Google Scholar
• Chahwan R, Edelmann W, Scharff MD, Roa S. 2011. Mismatch-mediated error prone repair at the immunoglobulin genes. Biomed. Pharmacother. 65:529–536. http://dx.doi.org/10.1016/j.biopha.2011.09.001.
   PubMedGoogle Scholar
• Unniraman S, Schatz DG. 2005. Strand-biased spreading of mutations during somatic hypermutation. Science 317:1227–1230. http://dx.doi.org/10.1126/science.1145065.
   Google Scholar
• Torres R, Kühn R. 1997. Laboratory protocols for conditional gene targeting. Oxford University Press, Oxford, United Kingdom.
   Google Scholar
• Delbos F, De Smet A, Faili A, Aoufouchi S, Weill JC, Reynaud CA. 2005. Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 201:1191–1196. http://dx.doi.org/10.1084/jem.20050292.
   PubMed Web of Science ®Google Scholar
• Cochran W. 1954. Some methods for strengthening the common chi-squared tests. Biometrics 10:417–451. http://dx.doi.org/10.2307/3001616.
   Web of Science ®Google Scholar
• Hollander M, Wolfe D. 1999. Wiley series in probability and statistics. John Wiley and Sons, New York, NY.
   Google Scholar
• Matsuda T, Bebenek K, Masutani C, Rogozin IB, Hanaoka F, Kunkel TA. 2001. Error rate and specificity of human and murine DNA polymerase eta. J. Mol. Biol. 312:335–346. http://dx.doi.org/10.1006/jmbi.2001.4937.
   PubMed Web of Science ®Google Scholar
• Pavlov YI, Rogozin IB, Galkin AP, Aksenova AY, Hanaoka F, Rada C, Kunkel TA. 2002. Correlation of somatic hypermutation specificity and A-T base pair substitution errors by DNA polymerase eta during copying of a mouse immunoglobulin kappa light chain transgene. Proc. Natl. Acad. Sci. U. S. A. 99:9954–9959. http://dx.doi.org/10.1073/pnas.152126799.
   PubMed Web of Science ®Google Scholar
• Spencer J, Dunn-Walters DK. 2005. Hypermutation at A-T base pairs: the A nucleotide replacement spectrum is affected by adjacent nucleotides and there is no reverse complementarity of sequences flanking mutated A and T nucleotides. J. Immunol. 175:5170–5177. http://dx.doi.org/10.4049/jimmunol.175.8.5170.
   PubMedGoogle Scholar
• Schanz S, Castor D, Fischer F, Jiricny J. 2009. Interference of mismatch and base excision repair during the processing of adjacent U/G mispairs may play a key role in somatic hypermutation. Proc. Natl. Acad. Sci. U. S. A. 106:5593–5598. http://dx.doi.org/10.1073/pnas.0901726106.
   PubMedGoogle Scholar
• Pena-Diaz J, Bregenhorn S, Ghodgaonkar M, Follonier C, Artola-Boran M, Castor D, Lopes M, Sartori AA, Jiricny J. 2012. Noncanonical mismatch repair as a source of genomic instability in human cells. Mol. Cell 47:669–680. http://dx.doi.org/10.1016/j.molcel.2012.07.006.
   PubMed Web of Science ®Google Scholar
• Xue K, Rada C, Neuberger MS. 2006. The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2−/− ung−/− mice. J. Exp. Med. 203:2085–2094. http://dx.doi.org/10.1084/jem.20061067.
   PubMed Web of Science ®Google Scholar
• van Oers JM, Roa S, Werling U, Liu Y, Genschel J, Hou HJr, Sellers RS, Modrich P, Scharff MD, Edelmann W. 2010. PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance. Proc. Natl. Acad. Sci. U. S. A. 107:13384–13389. http://dx.doi.org/10.1073/pnas.1008589107.
   PubMed Web of Science ®Google Scholar
• Maccarthy T, Roa S, Scharff MD, Bergman A. 2009. SHMTool: a webserver for comparative analysis of somatic hypermutation datasets. DNA Repair (Amst) 8:137–141. http://dx.doi.org/10.1016/j.dnarep.2008.09.006.
   PubMedGoogle Scholar
• Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinsk M, Jager N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdes-Mas R, van Buuren MM, van't Veer L, Vincent-Salomon A, Waddell N, Yates LR, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR. 2013. Signatures of mutational processes in human cancer. Nature 500:415–421. http://dx.doi.org/10.1038/nature12477.
   PubMed Web of Science ®Google Scholar